Sodium‐glucose co‐transporter‐2 inhibitors for type 1 diabetes: Not any more?

Saved in:
Bibliographic Details
Published in:Diabetes, obesity & metabolism obesity & metabolism, 2022-04, Vol.24 (4), p.764-765
Main Authors: Czupryniak, Leszek, Danne, Thomas, Szymańska‐Garbacz, Elektra, Zozulińska‐Ziółkiewicz, Dorota, Gumprecht, Janusz, Klupa, Tomasz
Format: Article
Language:English
Subjects:
Diabetes mellitus (insulin dependent)
Diabetes Mellitus, Type 1 - drug therapy
Glucose
Glucose transporter
Humans
Hypoglycemic Agents - adverse effects
Sodium
Sodium-Glucose Transporter 2
Sodium-Glucose Transporter 2 Inhibitors - therapeutic use
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites
container_end_page 765
container_issue 4
container_start_page 764
container_title Diabetes, obesity & metabolism
container_volume 24
creator Czupryniak, Leszek
Danne, Thomas
Szymańska‐Garbacz, Elektra
Zozulińska‐Ziółkiewicz, Dorota
Gumprecht, Janusz
Klupa, Tomasz
description
doi_str_mv 10.1111/dom.14631
format article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_proquest_miscellaneous_2612389354</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2637240300</sourcerecordid><originalsourceid>FETCH-LOGICAL-p2791-564c2e381e8e334e6057e420265dee8872caf8eb1d97bd7131866b6083121de33</originalsourceid><addsrcrecordid>eNpdkUtOwzAQhi0EoqWw4ALIEhs2af2K47BBqDylQheFtZXHFFIlcbAToew4AmfkJLilsGA2M7_mm9FofoSOKRlTH5PcVGMqJKc7aLjOAeVM7m5qFqiYsAE6cG5FCBFcRftowEXMqWBqiBYLkxdd9fXx-VJ2mXGAM-NFa5PaNca2YL1iuKhfi7RojXV4aSxu-wYwxXmRpNCCO8ePpsVJ3ePKWLg4RHvLpHRwtM0j9Hxz_TS9C2bz2_vp5SxoWBTTIJQiY8AVBQWcC5AkjEAwwmSYAygVsSxZKkhpHkdpHlFOlZSpJIpTRnM_MkJnP3sba946cK2uCpdBWSY1mM5pJinjKuah8OjpP3RlOlv76zzFIyYIJ8RTJ1uqSyvIdWOLKrG9_n2XByY_wHtRQv_Xp0SvfdDeB73xQV_NHzYF_wbdjnqp</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2637240300</pqid></control><display><type>article</type><title>Sodium‐glucose co‐transporter‐2 inhibitors for type 1 diabetes: Not any more?</title><source>Wiley-Blackwell Read &amp; Publish Collection</source><creator>Czupryniak, Leszek ; Danne, Thomas ; Szymańska‐Garbacz, Elektra ; Zozulińska‐Ziółkiewicz, Dorota ; Gumprecht, Janusz ; Klupa, Tomasz</creator><creatorcontrib>Czupryniak, Leszek ; Danne, Thomas ; Szymańska‐Garbacz, Elektra ; Zozulińska‐Ziółkiewicz, Dorota ; Gumprecht, Janusz ; Klupa, Tomasz</creatorcontrib><identifier>ISSN: 1462-8902</identifier><identifier>EISSN: 1463-1326</identifier><identifier>DOI: 10.1111/dom.14631</identifier><identifier>PMID: 34931428</identifier><language>eng</language><publisher>Oxford, UK: Blackwell Publishing Ltd</publisher><subject>Diabetes mellitus (insulin dependent) ; Diabetes Mellitus, Type 1 - drug therapy ; Glucose ; Glucose transporter ; Humans ; Hypoglycemic Agents - adverse effects ; Sodium ; Sodium-Glucose Transporter 2 ; Sodium-Glucose Transporter 2 Inhibitors - therapeutic use</subject><ispartof>Diabetes, obesity &amp; metabolism, 2022-04, Vol.24 (4), p.764-765</ispartof><rights>2021 John Wiley &amp; Sons Ltd</rights><rights>2022 John Wiley &amp; Sons Ltd</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><orcidid>0000-0002-7199-4079 ; 0000-0001-7692-1138 ; 0000-0002-8424-3944 ; 0000-0003-2995-9971 ; 0000-0001-7091-2118 ; 0000-0003-2396-8885</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27922,27923</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/34931428$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Czupryniak, Leszek</creatorcontrib><creatorcontrib>Danne, Thomas</creatorcontrib><creatorcontrib>Szymańska‐Garbacz, Elektra</creatorcontrib><creatorcontrib>Zozulińska‐Ziółkiewicz, Dorota</creatorcontrib><creatorcontrib>Gumprecht, Janusz</creatorcontrib><creatorcontrib>Klupa, Tomasz</creatorcontrib><title>Sodium‐glucose co‐transporter‐2 inhibitors for type 1 diabetes: Not any more?</title><title>Diabetes, obesity &amp; metabolism</title><addtitle>Diabetes Obes Metab</addtitle><subject>Diabetes mellitus (insulin dependent)</subject><subject>Diabetes Mellitus, Type 1 - drug therapy</subject><subject>Glucose</subject><subject>Glucose transporter</subject><subject>Humans</subject><subject>Hypoglycemic Agents - adverse effects</subject><subject>Sodium</subject><subject>Sodium-Glucose Transporter 2</subject><subject>Sodium-Glucose Transporter 2 Inhibitors - therapeutic use</subject><issn>1462-8902</issn><issn>1463-1326</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><recordid>eNpdkUtOwzAQhi0EoqWw4ALIEhs2af2K47BBqDylQheFtZXHFFIlcbAToew4AmfkJLilsGA2M7_mm9FofoSOKRlTH5PcVGMqJKc7aLjOAeVM7m5qFqiYsAE6cG5FCBFcRftowEXMqWBqiBYLkxdd9fXx-VJ2mXGAM-NFa5PaNca2YL1iuKhfi7RojXV4aSxu-wYwxXmRpNCCO8ePpsVJ3ePKWLg4RHvLpHRwtM0j9Hxz_TS9C2bz2_vp5SxoWBTTIJQiY8AVBQWcC5AkjEAwwmSYAygVsSxZKkhpHkdpHlFOlZSpJIpTRnM_MkJnP3sba946cK2uCpdBWSY1mM5pJinjKuah8OjpP3RlOlv76zzFIyYIJ8RTJ1uqSyvIdWOLKrG9_n2XByY_wHtRQv_Xp0SvfdDeB73xQV_NHzYF_wbdjnqp</recordid><startdate>202204</startdate><enddate>202204</enddate><creator>Czupryniak, Leszek</creator><creator>Danne, Thomas</creator><creator>Szymańska‐Garbacz, Elektra</creator><creator>Zozulińska‐Ziółkiewicz, Dorota</creator><creator>Gumprecht, Janusz</creator><creator>Klupa, Tomasz</creator><general>Blackwell Publishing Ltd</general><general>Wiley Subscription Services, Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>7T5</scope><scope>7TK</scope><scope>H94</scope><scope>K9.</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0002-7199-4079</orcidid><orcidid>https://orcid.org/0000-0001-7692-1138</orcidid><orcidid>https://orcid.org/0000-0002-8424-3944</orcidid><orcidid>https://orcid.org/0000-0003-2995-9971</orcidid><orcidid>https://orcid.org/0000-0001-7091-2118</orcidid><orcidid>https://orcid.org/0000-0003-2396-8885</orcidid></search><sort><creationdate>202204</creationdate><title>Sodium‐glucose co‐transporter‐2 inhibitors for type 1 diabetes: Not any more?</title><author>Czupryniak, Leszek ; Danne, Thomas ; Szymańska‐Garbacz, Elektra ; Zozulińska‐Ziółkiewicz, Dorota ; Gumprecht, Janusz ; Klupa, Tomasz</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-p2791-564c2e381e8e334e6057e420265dee8872caf8eb1d97bd7131866b6083121de33</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Diabetes mellitus (insulin dependent)</topic><topic>Diabetes Mellitus, Type 1 - drug therapy</topic><topic>Glucose</topic><topic>Glucose transporter</topic><topic>Humans</topic><topic>Hypoglycemic Agents - adverse effects</topic><topic>Sodium</topic><topic>Sodium-Glucose Transporter 2</topic><topic>Sodium-Glucose Transporter 2 Inhibitors - therapeutic use</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Czupryniak, Leszek</creatorcontrib><creatorcontrib>Danne, Thomas</creatorcontrib><creatorcontrib>Szymańska‐Garbacz, Elektra</creatorcontrib><creatorcontrib>Zozulińska‐Ziółkiewicz, Dorota</creatorcontrib><creatorcontrib>Gumprecht, Janusz</creatorcontrib><creatorcontrib>Klupa, Tomasz</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>Immunology Abstracts</collection><collection>Neurosciences Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>MEDLINE - Academic</collection><jtitle>Diabetes, obesity &amp; metabolism</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Czupryniak, Leszek</au><au>Danne, Thomas</au><au>Szymańska‐Garbacz, Elektra</au><au>Zozulińska‐Ziółkiewicz, Dorota</au><au>Gumprecht, Janusz</au><au>Klupa, Tomasz</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Sodium‐glucose co‐transporter‐2 inhibitors for type 1 diabetes: Not any more?</atitle><jtitle>Diabetes, obesity &amp; metabolism</jtitle><addtitle>Diabetes Obes Metab</addtitle><date>2022-04</date><risdate>2022</risdate><volume>24</volume><issue>4</issue><spage>764</spage><epage>765</epage><pages>764-765</pages><issn>1462-8902</issn><eissn>1463-1326</eissn><cop>Oxford, UK</cop><pub>Blackwell Publishing Ltd</pub><pmid>34931428</pmid><doi>10.1111/dom.14631</doi><tpages>2</tpages><orcidid>https://orcid.org/0000-0002-7199-4079</orcidid><orcidid>https://orcid.org/0000-0001-7692-1138</orcidid><orcidid>https://orcid.org/0000-0002-8424-3944</orcidid><orcidid>https://orcid.org/0000-0003-2995-9971</orcidid><orcidid>https://orcid.org/0000-0001-7091-2118</orcidid><orcidid>https://orcid.org/0000-0003-2396-8885</orcidid></addata></record>
fulltext fulltext
identifier ISSN: 1462-8902
ispartof Diabetes, obesity & metabolism, 2022-04, Vol.24 (4), p.764-765
issn 1462-8902
1463-1326
language eng
recordid cdi_proquest_miscellaneous_2612389354
source Wiley-Blackwell Read & Publish Collection
subjects Diabetes mellitus (insulin dependent)
Diabetes Mellitus, Type 1 - drug therapy
Glucose
Glucose transporter
Humans
Hypoglycemic Agents - adverse effects
Sodium
Sodium-Glucose Transporter 2
Sodium-Glucose Transporter 2 Inhibitors - therapeutic use
title Sodium‐glucose co‐transporter‐2 inhibitors for type 1 diabetes: Not any more?
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-14T13%3A09%3A40IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Sodium%E2%80%90glucose%20co%E2%80%90transporter%E2%80%902%20inhibitors%20for%20type%201%20diabetes:%20Not%20any%20more?&rft.jtitle=Diabetes,%20obesity%20&%20metabolism&rft.au=Czupryniak,%20Leszek&rft.date=2022-04&rft.volume=24&rft.issue=4&rft.spage=764&rft.epage=765&rft.pages=764-765&rft.issn=1462-8902&rft.eissn=1463-1326&rft_id=info:doi/10.1111/dom.14631&rft_dat=%3Cproquest_pubme%3E2637240300%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-p2791-564c2e381e8e334e6057e420265dee8872caf8eb1d97bd7131866b6083121de33%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2637240300&rft_id=info:pmid/34931428&rfr_iscdi=true